Literature DB >> 17127559

Amyotrophic lateral sclerosis: prognostic indicators of survival.

Jessica Mandrioli1, Pietro Faglioni, Paolo Nichelli, Patrizia Sola.   

Abstract

Amyotrophic lateral sclerosis (ALS) has a fatal outcome in about three years, but survival is known to vary considerably, making it difficult to predict disease duration in individual cases. The aim of this study was to investigate possible early prognostic factors of ALS survival. We included 123 probable or definite cases of ALS, with disease onset between 1989 and 1998, and with a follow-up of at least one year. Survival functions were obtained using both the Kaplan-Meier and the actuarial methods. Subgroups, formed on the basis of gender, area of residence, work, and age at and site of onset, were compared using the logrank test and Cox's proportional hazards method (survival functions), and applying the Grizzle, Starmer, Koch (1969), and Koch, Johnson, Tolley (1972) methods (one-year survival probability trends). The survival curves dipped sharply in the first three years, followed by a flattening trend, with 50% of patients dying within 2.5 years, and 89% over seven years. The clinical form with lower limb onset was associated with longer survival than the upper limb onset and bulbar forms (median survival: 39, 27, and 25 months, respectively). Survival was also affected by age at onset (median survival: 34, 27, and 23 months for onset <60, 60-75, and >75 years, respectively), area of residence (median survival: 24 months in mountainous areas, 32 elsewhere), and type of work (median survival: 25 months in agricultural workers, 33.5 in others). Gender did not influence survival, whereas percutaneous endoscopic gastrostomy placement and invasive ventilation did. The estimation of individual ALS survival is important to allow the patient to plan for his future and to make optimal use of medical and community resources. Although age at and site of onset, area of residence, and agricultural work were found to influence survival, there remains an unexplained heterogeneous progression of the disease, suggesting the influence of other, as yet unknown, prognostic factors. The identification of a definite set of prognostic factors may allow physicians to make more reliable survival predictions at diagnosis.

Entities:  

Mesh:

Year:  2006        PMID: 17127559     DOI: 10.1080/17482960600947648

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler        ISSN: 1471-180X


  16 in total

Review 1.  Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis etiology and survival.

Authors:  John D Beard; Freya Kamel
Journal:  Epidemiol Rev       Date:  2014-10-31       Impact factor: 6.222

Review 2.  Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin.

Authors:  Benoît Marin; Giancarlo Logroscino; Farid Boumédiene; Anaïs Labrunie; Philippe Couratier; Marie-Claude Babron; Anne Louise Leutenegger; Pierre Marie Preux; Ettore Beghi
Journal:  Eur J Epidemiol       Date:  2015-10-12       Impact factor: 8.082

3.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

4.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

Review 5.  Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?

Authors:  Neta Zach; David L Ennist; Albert A Taylor; Hagit Alon; Alexander Sherman; Robert Kueffner; Jason Walker; Ervin Sinani; Igor Katsovskiy; Merit Cudkowicz; Melanie L Leitner
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

6.  Structural explanation of poor prognosis of amyotrophic lateral sclerosis in the non-demented state.

Authors:  H-J Kim; S-I Oh; M de Leon; X Wang; K-W Oh; J-S Park; A Deshpande; M Buj; S H Kim
Journal:  Eur J Neurol       Date:  2016-10-18       Impact factor: 6.089

Review 7.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

8.  The use of full-setting non-invasive ventilation in the home care of people with amyotrophic lateral sclerosis-motor neuron disease with end-stage respiratory muscle failure: a case series.

Authors:  Eduardo L De Vito; Adrián A Suárez; Sergio G Monteiro
Journal:  J Med Case Rep       Date:  2012-01-30

9.  Long-Term Use of Riluzole Could Improve the Prognosis of Sporadic Amyotrophic Lateral Sclerosis Patients: A Real-World Cohort Study in China.

Authors:  Lu Chen; Xiaolu Liu; Lu Tang; Nan Zhang; Dongsheng Fan
Journal:  Front Aging Neurosci       Date:  2016-10-24       Impact factor: 5.750

10.  Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival.

Authors:  John D Beard; Lawrence S Engel; David B Richardson; Marilie D Gammon; Coleen Baird; David M Umbach; Kelli D Allen; Catherine L Stanwyck; Jean Keller; Dale P Sandler; Silke Schmidt; Freya Kamel
Journal:  PLoS One       Date:  2017-10-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.